首页> 美国卫生研究院文献>Nucleic Acids Research >Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
【2h】

Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.

机译:与融合肽偶联的反义寡核苷酸的生物学活性得到改善。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recently several groups reported a dramatic improvement of reporter gene transfection efficiency using a fusogenic peptide, derived from the Influenza hemagglutinin envelop protein. This peptide changes conformation at acidic pH and destabilizes the endosomal membranes thus resulting in an increased cytoplasmic gene delivery. We describe the use of a similar fusogenic peptide in order to improve the antiviral potency of antisense oligodeoxynucleotides (anti TAT) and oligophosphorothioates (S-dC28) on de novo HIV infected CEM-SS lymphocytes in serum-free medium. We observed as 5 to 10 fold improvement of the anti HIV activities of the phosphodiester antisense oligonucleotides after chemical coupling to the peptide in a one to one ratio by a disulfide or thioether bond. No toxicities were observed at the effective doses (0.1-1 microM). No sequence specificity was obtained and the fusogenic peptide possessed some antiviral activities on its own (IC50: 6 microM). A S-dC28-peptide disulfide linked conjugate and a streptavidin-peptide-biotinylated S-dC28 adduct showed similar activities as the free S-dC28 oligonucleotide (IC50: 0.1-1 nM). As expected, all the compounds were less potent in the presence of serum but the relative contribution of peptide coupling was maintained.
机译:最近,几个小组报道了使用融合肽衍生的报告基因转染效率的显着提高,所述融合肽衍生自流感血凝素包膜蛋白。该肽在酸性pH下改变构象并使内体膜不稳定,从而导致细胞质基因递送增加。我们描述了使用类似的融合肽,以提高无血清培养基中从头感染HIV的CEM-SS淋巴细胞上反义寡脱氧核苷酸(抗TAT)和寡硫代磷酸酯(S-dC28)的抗病毒效力。我们观察到,通过二硫键或硫醚键以一对一的比例与肽化学偶联后,磷酸二酯反义寡核苷酸的抗HIV活性提高了5到10倍。在有效剂量(0.1-1 microM)下未观察到毒性。没有获得序列特异性,并且融合肽本身具有一些抗病毒活性(IC50:6 microM)。 S-dC28-肽二硫键连接的缀合物和链霉亲和素-肽生物素化的S-dC28加合物显示出与游离S-dC28寡核苷酸相似的活性(IC50:0.1-1 nM)。如所期望的,所有化合物在血清存在下效力均较低,但是肽偶联的相对贡献得以维持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号